Lee JH, Lee JE, Kahng JY, Kim SH, Park JS, Yoon SJ, et al. Human glioblastoma arises from subventricular zone cells with low-level driver mutations. Nature. 2018;560(7717):243–7.

Article  CAS  PubMed  Google Scholar 

Ludwig K, Kornblum HI. Molecular markers in glioma. J Neurooncol. 2017;134(3):505–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Davis ME. Epidemiology and overview of gliomas. Semin Oncol Nurs. 2018;34(5):420–9.

Article  PubMed  Google Scholar 

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng JX, Liu BL, Zhang X, Lin W, Zhang YQ, Liu WP, et al. Health-related quality of life in glioma patients in China. BMC Cancer. 2010;10:305.

Article  PubMed  PubMed Central  Google Scholar 

Robertson ME, McSherry F, Herndon JE, Peters KB. Insomnia and its associations in patients with recurrent glial neoplasms. Springerplus. 2016;5(1):823.

Article  PubMed  PubMed Central  Google Scholar 

Jeon MS, Dhillon HM, Koh ES, Nowak AK, Hovey E, Descallar J, et al. Exploring sleep disturbance among adults with primary or secondary malignant brain tumors and their caregivers. Neurooncol Pract. 2021;8(1):48–59.

PubMed  Google Scholar 

Mogavero MP, DelRosso LM, Fanfulla F, Bruni O, Ferri R. Sleep disorders and cancer: state of the art and future perspectives. Sleep Med Rev. 2021;56: 101409.

Article  PubMed  Google Scholar 

Walker WH, 2nd, Borniger JC. Molecular mechanisms of cancer-induced sleep disruption. Int J Mol Sci. 2019;20(11):2780.

Schieber K, Niecke A, Geiser F, Erim Y, Bergelt C, Buttner-Teleaga A, et al. The course of cancer-related insomnia: don’t expect it to disappear after cancer treatment. Sleep Med. 2019;58:107–13.

Article  PubMed  Google Scholar 

Andersen BL, Goyal NG, Westbrook TD, Bishop B, Carson WE 3rd. Trajectories of stress, depressive symptoms, and immunity in cancer survivors: diagnosis to 5 years. Clin Cancer Res. 2017;23(1):52–61.

Article  PubMed  Google Scholar 

Gapstur SM, Diver WR, Stevens VL, Carter BD, Teras LR, Jacobs EJ. Work schedule, sleep duration, insomnia, and risk of fatal prostate cancer. Am J Prev Med. 2014;46(3 Suppl 1):S26-33.

Article  PubMed  Google Scholar 

Chen J, Chen N, Huang T, Huang N, Zhuang Z, Liang H. Sleep pattern, healthy lifestyle and colorectal cancer incidence. Sci Rep. 2022;12(1):18317.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peeters MCM, Dirven L, Koekkoek JAF, Gortmaker EG, Fritz L, Vos MJ, et al. Prediagnostic symptoms and signs of adult glioma: the patients’ view. J Neurooncol. 2020;146(2):293–301.

Article  CAS  PubMed  Google Scholar 

Borbely A. The two-process model of sleep regulation: beginnings and outlook. J Sleep Res. 2022;31(4): e13598.

Article  PubMed  PubMed Central  Google Scholar 

Takahashi JS. Transcriptional architecture of the mammalian circadian clock. Nat Rev Genet. 2017;18(3):164–79.

Article  CAS  PubMed  Google Scholar 

Rijo-Ferreira F, Takahashi JS. Genomics of circadian rhythms in health and disease. Genome Med. 2019;11(1):82.

Article  PubMed  PubMed Central  Google Scholar 

Charrier A, Olliac B, Roubertoux P, Tordjman S. Clock genes and altered sleep-wake rhythms: their role in the development of psychiatric disorders. Int J Mol Sci. 2017. https://doi.org/10.3390/ijms18050938.

Article  PubMed  PubMed Central  Google Scholar 

Kinouchi K, Sassone-Corsi P. Metabolic rivalry: circadian homeostasis and tumorigenesis. Nat Rev Cancer. 2020;20(11):645–61.

Article  CAS  PubMed  Google Scholar 

De La Cruz Minyety J, Shuboni-Mulligan DD, Briceno N, Young D Jr, Gilbert MR, Celiku O, et al. Association of circadian clock gene expression with glioma tumor microenvironment and patient survival. Cancers (Basel). 2021. https://doi.org/10.3390/cancers13112756.

Article  PubMed  Google Scholar 

Chen P, Hsu WH, Chang A, Tan Z, Lan Z, Zhou A, et al. Circadian regulator CLOCK recruits immune-suppressive microglia into the GBM tumor microenvironment. Cancer Discov. 2020;10(3):371–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang WH, Lai AG. Timing gone awry: distinct tumour suppressive and oncogenic roles of the circadian clock and crosstalk with hypoxia signalling in diverse malignancies. J Transl Med. 2019;17(1):132.

Article  PubMed  PubMed Central  Google Scholar 

Wang Z, Su G, Dai Z, Meng M, Zhang H, Fan F, et al. Circadian clock genes promote glioma progression by affecting tumour immune infiltration and tumour cell proliferation. Cell Prolif. 2021;54(3): e12988.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bevinakoppamath S, Ramachandra SC, Yadav AK, Basavaraj V, Vishwanath P, Prashant A. Understanding the emerging link between circadian rhythm, Nrf2 pathway, and breast cancer to overcome drug resistance. Front Pharmacol. 2021;12: 719631.

Article  CAS  PubMed  Google Scholar 

He L, Fan Y, Zhang Y, Tu T, Zhang Q, Yuan F, et al. Single-cell transcriptomic analysis reveals circadian rhythm disruption associated with poor prognosis and drug-resistance in lung adenocarcinoma. J Pineal Res. 2022;73(1): e12803.

Article  CAS  PubMed  Google Scholar 

Miyauchi JT, Tsirka SE. Advances in immunotherapeutic research for glioma therapy. J Neurol. 2018;265(4):741–56.

Article  CAS  PubMed  Google Scholar 

Xu S, Tang L, Li X, Fan F, Liu Z. Immunotherapy for glioma: current management and future application. Cancer Lett. 2020;476:1–12.

Article  CAS  PubMed  Google Scholar 

Slat EA, Sponagel J, Marpegan L, Simon T, Kfoury N, Kim A, et al. Cell-intrinsic, Bmal1-dependent circadian regulation of temozolomide sensitivity in glioblastoma. J Biol Rhythms. 2017;32(2):121–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Katamune C, Koyanagi S, Hashikawa KI, Kusunose N, Akamine T, Matsunaga N, et al. Mutation of the gene encoding the circadian clock component PERIOD2 in oncogenic cells confers chemoresistance by up-regulating the Aldh3a1 gene. J Biol Chem. 2019;294(2):547–58.

Article  CAS  PubMed  Google Scholar 

Barthel L, Hadamitzky M, Dammann P, Schedlowski M, Sure U, Thakur BK, et al. Glioma: molecular signature and crossroads with tumor microenvironment. Cancer Metastasis Rev. 2022;41(1):53–75.

Article  CAS  PubMed  Google Scholar 

Cole AP, Hoffmeyer E, Chetty SL, Cruz-Cruz J, Hamrick F, Youssef O, et al. Microglia in the brain tumor microenvironment. Adv Exp Med Biol. 2020;1273:197–208.

Article  CAS  PubMed  Google Scholar 

Goenka A, Tiek D, Song X, Huang T, Hu B, Cheng SY. The many facets of therapy resistance and tumor recurrence in glioblastoma. Cells. 2021. https://doi.org/10.3390/cells10030484.

Article  PubMed  PubMed Central